51 results on '"Moskalenko, Marina"'
Search Results
2. Movie S2 from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
3. Movie S2 Legend from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
4. Data from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
5. Database of flow cytometry parameters in tumor models from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
6. Data from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
7. Movie S1 from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
8. Supplementary Materials and Methods from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
9. Supplementary Figures and Tables from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
10. Movie S2 from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
11. Movie S2 Legend from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
12. Movie S1 Legend from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
13. Movie S1 from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
14. Supplementary Figures and Tables from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
15. Movie S1 Legend from Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
16. Supplemental Figure S3 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
17. Supplemental Methods from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
18. Supplemental Figure Legends from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
19. Supplemental Figure S2 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
20. Data from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
21. Supplemental Figure S5 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
22. Supplemental Figure S1 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
23. Supplemental Methods from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
24. Supplemental Figure S5 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
25. Supplemental Figure S1 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
26. Supplemental Figure S4 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
27. Supplemental Figure Legends from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
28. Supplemental Figure S4 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
29. Data from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
30. Supplemental Figure S2 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
31. Supplemental Figure S3 from Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
32. Supplementary Data from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
33. Figure S1 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
34. Figure S6 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
35. Data from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
36. Supplementary Data from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
37. Figure S5 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
38. Figure S4 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
39. Figure S6 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
40. Figure S3 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
41. Figure S3 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
42. Figure S5 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
43. Figure S4 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
44. Table S1 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
45. Figure S2 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
46. Figure S1 from Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
47. Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
48. Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
49. Abstract A114: Effect of different standard of care chemotherapeutics on anti-PD-L1 responses in syngeneic mouse tumor models
50. Requirement for Innate Immunity and CD90+ NK1.1− Lymphocytes to Treat Established Melanoma with Chemo-Immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.